NASDAQ OMX

Metron Wins Air Traffic Flow Management Contract From Civil Aviation Authority of Singapore

Dela

DULLES, Va., Jan. 30, 2018 (GLOBE NEWSWIRE) -- The Civil Aviation Authority of Singapore (CAAS) has awarded Metron Aviation, a subsidiary of Airbus, an Air Traffic Flow Management (ATFM) system contract. This system will be located at the Singapore Air Traffic Control Centre (SATCC). 

Metron will be responsible for the design, supply, delivery, installation, integration, testing and commissioning of the ATFM system over a 23-month period and a 10-year after sales support service beginning after initial system acceptance.

Metron will supply Harmony, its flagship ATFM automation product for air navigation service providers. Harmony provides advanced features to monitor air traffic demand in airspace areas and at airports in the strategic, pre-tactical, and tactical timeframes. Harmony also provides advanced decision support tools to facilitate the modeling of Traffic Management Initiatives (TMI) and the implementation of these initiatives in situations of demand and capacity imbalance.

Harmony also provides complete functionality for aircraft operator's collaborative decision making in the ATFM process to ensure that ATFM actions reflect a plan optimized across all aviation system participants.

"We are proud to have been selected for this contract by CAAS, a premier provider of air navigation services," said John Kefaliotis, President, Metron Aviation. "CAAS has a leadership role in the development of a regional ATFM concept for the Asia-Pacific region that will become a model for regional ATFM cooperation around the world." 

"The CAAS selection of the Harmony platform to support this concept testifies to the advanced capabilities of the product, which are highly supportive of regional ATFM concepts," said Kefaliotis.

The contract duration is approximately 11 years, with the following major milestones:

  • Phase 1: Commissioning of the operational ATFM system, to occur 10 months after award;
  • Phase 2: Commissioning of the ATFM system's enhanced services, scheduled for 20 months after award;
  • Completion of the system, which will occur three months after commissioning of Phase 2; and
  • Ten annual options for support services for both hardware and software.

Metron will be responsible for the overall system implementation and maintenance over the duration of the contract. Metron Aviation is teamed with Singapore Technologies Electronic Limited, which will provide in-country services to include acquisition, storage, installation and maintenance of the primary equipment, as well as spare parts, for the duration of the contract.

About Metron Aviation
Founded in 1995, Metron Aviation is a trusted and proven innovator in the air traffic management (ATM) industry. A subsidiary of Airbus Americas, Metron Aviation has an honored past, developing ATM and air traffic flow management solutions for the global aviation industry, including the Federal Aviation Administration. By working with all stakeholders in the ATM ecosystem - air navigation service providers, airlines, airports, civil aviation authorities and other influencers - through its Collaborative Decision Making (CDM) process, Metron Aviation understands ATM's greatest issues. It fuses advanced science and mathematics with unparalleled subject-matter expertise to turn groundbreaking ATM research concepts into next-generation operational capabilities. For more information, please visit www.metronaviation.com.

Contact:
Quentin Hunstad
Quentin.hunstad@airbus.com
571.306.7243 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Airbus Americas, Inc. via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Fentress Architects: The Future of Airports as Civic Spaces21.5.2018 22:27Pressmeddelande

The European Cultural Centre and Global Art Affairs Foundation invited Fentress Architects and North Carolina State University College of Design to participate in the 2018 Venice Architecture Biennale May 26-November 25, 2018, at the historic Palazzo Bembo. Denver, Colo. - May 21, 2018, May 21, 2018 (GLOBE NEWSWIRE) -- Architecture students from North Carolina State University College of Design will join Fentress at the Palazzo Bembo to present their designs for airports of the future. Fentress has been guiding students in preparation for the exhibition, which allows 11 students to embark on a once-in-a-lifetime opportunity to travel to Italy for the 2018 Venice Biennale of Architecture. Their designs will be featured in the "Time Space Existence" exhibit, offering the public a glimpse at the future of airport design. The students are participating in an Airport Design course with Principal in Charge of Design Curt Fentress, FAIA, RIBA, and Alumni Distinguished Professor of Architectur

Oxford Immunotec's T-SPOT®.TB Test Included in the World Health Organization's First-Ever Essential Diagnostics List21.5.2018 22:15Pressmeddelande

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 21, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that the Company's T-SPOT.TB test for tuberculosis (TB) infection has been included in the World Health Organization (WHO) Model List of Essential In Vitro Diagnostics (EDL) - First Edition. The EDL includes the 113 most important tests recommended by WHO for use at various levels of the health care system. These essential diagnostics satisfy the priority health care needs of the population and were selected with due regard to disease prevalence and public health relevance, evidence of efficacy and accuracy, and comparative cost-effectiveness. 58 of the tests listed are for the detection and diagnosis of a wide range of common conditions, providing an essential package that can form the basis for screening and management of patients. The remaining 55 tests are designed for the detection, diagnosis, and moni

Virgin Pulse and RedBrick Health Joining Forces to Create World's Largest Digital Employee Wellbeing and Engagement Company21.5.2018 17:00Pressmeddelande

Merger Will Create First and Only One-Stop-Shop for Employee Health, Wellbeing and Benefits Engagement; Combined Company Will Have More Than 3,300 Customers Across 190 Countries PROVIDENCE, R.I., May 21, 2018 (GLOBE NEWSWIRE) -- Providence-based Virgin Pulse and Minneapolis-based RedBrick Health announced today that the industry pioneers will merge, creating the world's largest, most comprehensive digital health and engagement company. This powerful combination will deliver the industry's only fully integrated digital platform, with benefits navigation and live coaching to support global clients and members across the entire health, wellbeing and benefits lifecycle - from screening and assessment to activation, behavior change and the adoption of sustainable, healthy habits. "We are thrilled to join with RedBrick to set a new vision and standard for employee health, wellbeing and engagement," said David Osborne, Virgin Pulse CEO, who will serve as CEO of the combined company. "Bringing

Hotels.com App Wins 2018 MediaPost Appy Award in Travel & Tourism Category21.5.2018 16:00Pressmeddelande

Developed by EPAM, app is recognized for creativity and excellence in app design NEWTOWN, Pa., May 21, 2018 (GLOBE NEWSWIRE) -- Hotels.com® and EPAM Systems, Inc. (NYSE:EPAM) announced their triumphant win at the 2018 MediaPost Appy Awards in the Travel and Tourism category this week. The Hotels.com mobile app, developed in collaboration with EPAM Systems, Inc., a leading global provider of digital platform engineering and software development services, has been crowned the best app developed for airlines, hotels, travel search engines, destinations, cruises, travel advice or car rentals. With over 70 million downloads and a 4.5+ star rating from consumers on both iOS and Android app stores, the Hotels.com app has now been recognized by the industry leading Appy Awards, which honor creativity and excellence in app design. The app provides a simple, fast and secure way for users to plan, book and manage hotel reservations, and allows travelers to book hundreds of thousands of places to

Karolinska Development's portfolio company Pharmanest appoints new CEO21.5.2018 15:01Pressmeddelande

STOCKHOLM, May 21, 2018. Karolinska Development's portfolio company Pharmanest AB announces the appointment of Helena Jansson as new Chief Executive Officer. Helena is an experienced life science executive, with a proven track record of successful business development and commercialization of pharmaceutical products. She replaces Gunilla Lundmark, who leaves her position after seven years. Helena Jansson has long experience in the life science industry and a broad knowledge base with a focus on business development and commercialization of pharmaceutical portfolios. She has spent a substantial part of her career at Medivir AB, in positions such as Business Unit Director, Head of Supply Chain and Director Alliance Management. In 2017, Pharmanest signed an outlicensing agreement with Gedeon Richter, a leading European pharmaceutical company within women's health. The agreement gives Gedeon Richter the marketing and sales rights to commercialize Pharmanest's first product SHACT (Short Act

Karolinska Development's portfolio company Pharmanest appoints new CEO21.5.2018 15:01Pressmeddelande

STOCKHOLM, May 21, 2018. Karolinska Development's portfolio company Pharmanest AB announces the appointment of Helena Jansson as new Chief Executive Officer. Helena is an experienced life science executive, with a proven track record of successful business development and commercialization of pharmaceutical products. She replaces Gunilla Lundmark, who leaves her position after seven years. Helena Jansson has long experience in the life science industry and a broad knowledge base with a focus on business development and commercialization of pharmaceutical portfolios. She has spent a substantial part of her career at Medivir AB, in positions such as Business Unit Director, Head of Supply Chain and Director Alliance Management. In 2017, Pharmanest signed an outlicensing agreement with Gedeon Richter, a leading European pharmaceutical company within women's health. The agreement gives Gedeon Richter the marketing and sales rights to commercialize Pharmanest's first product SHACT (Short Act

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum